Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
6.09% $0.0385
America/New_York / 3 mai 2024 @ 14:19
FUNDAMENTALS | |
---|---|
MarketCap: | 8.09 mill |
EPS: | -0.0800 |
P/E: | -0.480 |
Earnings Date: | May 07, 2024 |
SharesOutstanding: | 210.03 mill |
Avg Daily Volume: | 0.0754 mill |
RATING 2024-05-03 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Sell | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Sell | |
DE: | Strong Sell | |
P/E: | Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | |
Gr.Profit | n/a | |||||
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.480 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.02x |
Company: PE -0.480 | industry: PE 31.46 |
DISCOUNTED CASH FLOW VALUE |
---|
$0.0001 (-99.79%) $-0.0384 |
Date: 2024-05-05 |
Expected Trading Range (DAY) |
---|
$ 0.0345 - 0.0425 ( +/- 10.39%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-29 | Mullin Philip Blair | Sell | 50 000 | Stock Options |
2023-09-29 | Mullin Philip Blair | Buy | 50 000 | Common Stock |
2023-09-26 | Mullin Philip Blair | Buy | 10 334 | Common Stock |
2023-09-26 | Mullin Philip Blair | Buy | 1 666 | Common Stock |
2023-07-20 | Mullin Philip Blair | Sell | 50 000 | Stock Options |
INSIDER POWER |
---|
86.76 |
Last 66 transactions |
Buy: 12 667 059 | Sell: 5 360 000 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | $0.0385 (6.09% ) |
Volume | 0.0517 mill |
Avg. Vol. | 0.0754 mill |
% of Avg. Vol | 68.53 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Cryomass Technologies Inc. designs, sells, and commercializes cryo-mechanical system for the handling of harvested hemp, cannabis, and other high-value plants. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado.